Improved mitochondrial function with diet-induced increase in either docosahexaenoic acid or arachidonic acid in membrane phospholipids

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Khairallah, Ramzi J ^a   Kim, Junhwan ^b   O'Shea, Karen M ^a   O'Connell, Kelly A ^a   Brown, Bethany H ^a   Galvao, Tatiana ^a   Daneault, Caroline ^c   Des Rosiers, Christines ^c   Polster, Brian M ^a   Hoppel, Charles L ^b   Stanley, William C ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CALCIUM ION; CARDIOLIPIN; DOCOSAHEXAENOIC ACID; LINOLEIC ACID; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PHOSPHOLIPID; CALCIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; HEART FUNCTION; HEART MITOCHONDRION; LIPID ANALYSIS; LIPID COMPOSITION; LIPID DIET; MALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NONHUMAN; RAT; ANIMAL; DIET; METABOLISM; MITOCHONDRION; WISTAR RAT;

ARA; RATTUS;

ANIMALS; ARACHIDONIC ACID; CALCIUM; DIET; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; MALE; MITOCHONDRIA; PHOSPHOLIPIDS; RATS; RATS, WISTAR;

EID: 84859128216     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034402     Document Type: Article

References (31)

1. Ricchelli F, Sileikyte J, Bernardi P, (2011) Shedding light on the mitochondrial permeability transition. Biochim Biophys Acta 1807: 482-490.
2. Halestrap AP, (2010) A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Biochem Soc Trans 38: 841-860.
3. Khairallah RJ, Sparagna GC, Khanna N, O'shea KM, Hecker PA, et al. (2010) Dietary supplementation with docosahexaenoic acid, but not eicosapentaenoic acid, dramatically alters cardiac mitochondrial phospholipid fatty acid composition and prevents permeability transition. Biochim Biophys Acta 1797: 1555-1562.
4. Khairallah RJ, O'shea KM, Brown BH, Khanna N, Des Rosiers C, et al. (2010) Treatment with docosahexaenoic acid, but not eicosapentaenoic acid, delays Ca2+-induced mitochondria permeability transition in normal and hypertrophied myocardium. J Pharmacol Exp Ther 335: 155-162.
5. O'shea KM, Khairallah RJ, Sparagna GC, Xu W, Hecker PA, et al. (2009) Dietary omega-3 fatty acids alter cardiac mitochondrial phospholipid composition and delay Ca2+-induced permeability transition. J Mol Cell Cardiol 47: 819-827.
6. Schmitz G, Ecker J, (2008) The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 47: 147-155.
7. Duda MK, O'shea KM, Tintinu A, Xu W, Khairallah RJ, et al. (2009) Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res 81: 319-327.
8. Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, et al. (2011) Effects of n-3 Polyunsaturated Fatty Acids on Left Ventricular Function and Functional Capacity in Patients With Dilated Cardiomyopathy. J Am Coll Cardiol 57: 870-879.
9. Gissi-Hf I, (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372: 1223-1230.
10. Kinsey GR, McHowat J, Patrick KS, Schnellmann RG, (2007) Role of Ca2+-independent phospholipase A2gamma in Ca2+-induced mitochondrial permeability transition. J Pharmacol Exp Ther 321: 707-715.
11. Penzo D, Petronilli V, Angelin A, Cusan C, Colonna R, et al. (2004) Arachidonic acid released by phospholipase A2 activation triggers Ca2+-dependent apoptosis through the mitochondrial pathway. J Biol Chem 279: 25219-25225.
12. Sparagna GC, Lesnefsky EJ, (2009) Cardiolipin remodeling in the heart. J Cardiovasc Pharmacol 53: 290-301.
13. Schlame M, Towbin JA, Heerdt PM, Jehle R, DiMauro S, et al. (2002) Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann Neurol 51: 634-637.
14. Minkler PE, Hoppel CL, (2010) Separation and characterization of cardiolipin molecular species by reverse-phase ion pair high-performance liquid chromatography-mass spectrometry. J Lipid Res 51: 856-865.
15. Schlame M, Kelley RI, Feigenbaum A, Towbin JA, Heerdt PM, et al. (2003) Phospholipid abnormalities in children with Barth syndrome. J Am Coll Cardiol 42: 1994-1999.
16. Rosca M, Minkler P, Hoppel CL, (2011) Cardiac mitochondria in heart failure: Normal cardiolipin profile and increased threonine phosphorylation of complex IV. Biochim Biophys Acta 1807: 1373-1382.
17. Pepe S, Tsuchiya N, Lakatta EG, Hansford RG, (1999) PUFA and aging modulate cardiac mitochondrial membrane lipid composition and Ca2+ activation of PDH. Am J Physiol 276: H149-H158.
18. McMillin JB, Bick RJ, Benedict CR, (1992) Influence of dietary fish oil on mitochondrial function and response to ischemia. Am J Physiol 263: H1479-H1485.
19. Kawabata T, Hirota S, Hirayama T, Adachi N, Hagiwara C, et al. (2011) Age-related changes of dietary intake and blood eicosapentaenoic acid, docosahexaenoic acid, and arachidonic acid levels in Japanese men and women. Prostaglandins Leukot Essent Fatty Acids 84: 131-137.
20. Farina EK, Kiel DP, Roubenoff R, Schaefer EJ, Cupples LA, et al. (2011) Dietary intakes of arachidonic acid and alpha-linolenic acid are associated with reduced risk of hip fracture in older adults. J Nutr 141: 1146-1153.
21. Scorrano L, Penzo D, Petronilli V, Pagano F, Bernardi P, (2001) Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha aopototic signaling. J Biol Chem 276: 12035-12040.
22. Pompeia C, Lima T, Curi R, (2003) Arachidonic acid cytotoxicity: can arachidonic acid be a physiological mediator of cell death? Cell Biochem Funct 21: 97-104.
23. Williams SD, Gottlieb RA, (2002) Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is cardioprotective. Biochem J 362: 23-32.
24. Russo GL, (2009) Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 77: 937-946.
25. Seyberth HW, Oelz O, Kennedy T, Sweetman BJ, Danon A, et al. (1975) Increased arachidonate in lipids after administration to man: effects on prostaglandin biosynthesis. Clin Pharmacol Ther 18: 521-529.
26. Abeywardena MY, McLennan PL, Charnock JS, (1991) Differential effects of dietary fish oil on myocardial prostaglandin I2 and thromboxane A2 production. Am J Physiol 260: H379-H385.
27. Abeywardena MY, McLennan PL, Charnock JS, (1991) Changes in myocardial eicosanoid production following long-term dietary lipid supplementation in rats. Am J Clin Nutr 53: 1039S-1041S.
28. Gelinas R, Thompson-Legault J, Bouchard B, Daneault C, Mansour A, et al. (2011) Prolonged QT interval and lipid alterations beyond {beta}-oxidation in very long-chain acyl-CoA dehydrogenase null mouse hearts. Am J Physiol Heart Circ Physiol 301: H813-H823.
29. Christiansen K, (1975) Lipid extraction procedure for in vitro studies of glyceride synthesis with labeled fatty acids. Anal Biochem 66: 93-99.
30. Ingalls ST, Kriaris MS, Xu Y, DeWulf DW, Tserng KY, et al. (1993) Method for isolation of non-esterified fatty acids and several other classes of plasma lipids by column chromatography on silica gel. J Chromatogr 619: 9-19.
31. Palmer JW, Tandler B, Hoppel CL, (1977) Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J Biol Chem 252: 8731-8739.